Abstract
Significant progress has been made in the application of monoclonal antibody technology to clinical diagnosis of cancer and to management of the disease. Antibodies labeled with radioactive isotopes have been demonstrated to localize in tumors of the gastrointestinal tract (1–6), ovary (6), breast (6,7), and skin (8) and promise to be very helpful in identifying metastases in patients with these tumors. However, there remain several problems to be resolved before radiolabeled antibody detection of tumor foci will be applied as an accepted and routine diagnostic/prognostic procedure. Problems include antibody cross-reactivity with normal tissues (5,6,9,10), low level penetration of antibody into tumor tissue (5,9,10), and inhibitory effects of specific circulating antigen (11). Current research is focused on selecting antibodies with the most desirable characteristics for tumor detection, improving chemistries to allow use of more appropriate radionuclides, and defining the effective clinical applications with regard to the tumor types, tumor sites and available diagnostic equipment and procedures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D. M. Goldenberg, F. H. Deland, and E. Kim, Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning, N. Engl. J. Med. 298:1384 (1978).
C. Berche, J. P. Mach, J. D. Lumbroso, C. Langlais, F. Aubry, F. Buchegger, S. Carrel, P. Rougier, C. Parmentier, and M. Tubiana, Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: First clinical results using radiolabeled monoclonal antibodies against carcinoembryonic antigen, Br. Med. J. 285:1447 (1982).
J. F. Chatal, J. C. Saccavini, P. Fumoleau, J. Y. Douillard, C. Curtet, M. Kremer, B. LeMevel, and H. Koprowski, Immunoscintigraphy of colon carcinoma, J. Nucl. Med. 25:307 (1984).
N. C. Armitage, A. C. Perkins, M. V. Pimm, P. A. Farrands, R. W. Baldwin, and J. D. Hardcastle, The localization of an anti-tumor monoclonal antibody (791T/36) in gastrointestinal tumors, Br. J. Surgery 74:407 (1984).
J. P. Mach, J. F. Chatal, J. D. Lumbroso, F. Buchegger, M. Forni, J. Ritschard, C. Berche, J. Y. Douillard, S. Carrel, M. Herlyn, Z. Steplewski, and H. Koprowski, Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma, Cancer Res. 43:5593 (1983).
A. A. Epenetos, K. E. Britton, J. Mather, J. Shepherd, M. Granowska, J. Taylor-Papadimitriou, C. C. Nimmon, H. Durbin, L. R. Hawkins, and J.S. Malpas, Targeting of iodine-123-labeled tumor-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumors, Lancet 2:999 (1982).
R. M. Rainsbury, J. H. Westwood, R. C. Coombes, A. M. Neville, R. J. Ott, T. S. Kalivai, V. R. McCready, and J. C. Gazet, Location of metastatic breast carcinoma by a monoclonal antibody chelate labeled with indium-111, Lancet 2:934 (1983).
J. A. Carrasquillo, K. A. Krohn, P. Beaumier, R. W. McGuffin, J. P. Brown, K. Brown, K. E. Hellstrom, I. Hellstrom, and S. M. Larson, Diagnosis and therapy for solid tumors with radiolabeled antibodies and immune fragments, Cancer Treat. Rep. 68:317 (1984).
S. M. Larson, J. P. Brown, P. W. Wright, J. A. Carrasquillo, I. Hellstrom, and K. E. Hellstrom, Imaging of melanoma with I-131 labeled monoclonal antibodies, J. Nucl. Med. 24:123 (1983).
P. J. Moldofsky, J. Powe, C. B. Mulherne, U. Hammond, H. F. Sears, P.A. Gatenby, Z. Steplewski, and H. Koprowski, Metastatic colon carcinoma detected with radiolabeled F(ab′)2 monoclonal antibody fragments. Radiology 149:549 (1983).
P. L. Hagan, S. E. Halpern, A. Chen, L. Krishnan, J. Frincke, R. M. Bartholomew, G. S. David, and D. Carlo, In vivo kinetics of radiolabeled monoclonal anti-CEA antibodies in animal models, J. Nucl. Med. 26:1418 (1985).
R. K. Oldham, Monoclonal antibodies in cancer therapy, J. Clin. Oncol. 1:582 (1983).
R. Levy, and R. A. Miller, Tumor therapy with monoclonal antibodies, Fed. Proc. 42:2650 (1983).
H. V. Pimm, A. C. Perkins, N. C. Armitage, and R. W. Baldwin, The characteristics of blood borne radiolabels and the effect of antimouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients, J. Nucl. Med. 26:1011 (1985).
J. C. Reynolds, J. A. Carrasquillo, A. M. Keenan, M. E. Lora, P. Sugarbaker, P. Abrams, K. Foon, J. L. Mulshine, J. Roth, D. Colcher, J. Schlom, and S. M. Larson, Human anti-murine antibodies following immunoscintigraphy or therapy with radiolabelled monoclonal antibodies, J. Nucl. Med. 27:1022 (1986).
R. W. Schroff, K. A. Foon, S. M. Beatty, R. K. Oldham, and A. C. Morgan, Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy, Cancer Res. 45:869 (1985).
H. F. Sears, D. Herlyn, A. Steplewski, and H. Koprowski, Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma, J. Biol. Response Mod. 3:138 (1974).
D. L. Shawler, R. M. Bartholomew, L. M. Smith, and R. O. Dillman, Human immune response to multiple injections of murine monoclonal IgG, J. Immunol. 135:1530 (1985).
B. Ballou, J. M. Reiland, G. Levine, R. J. Taylor, W. C. Shen, H. J. Ryser, D. Solter, and T. R. Hakala, Tumor location and drug targeting using a monoclonal antibody (anti-SSEA-1) and antigen binding fragments, J. Surg. Oncol. 31:1 (1986).
T. Maillet, A. C. Roche, F. Therain, and M. Mosigny, Time course localization of immunoglobulin M monoclonal antibody and its fragments in leukemic tumor-bearing mice, Cancer Immunol. Immunother. 19:177 (1985).
S. L. Morrison, M. J. Johnson, L. A. Herzenbern, and Oi, V. T., Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains, Proc. Natl. Acad. Sci. USA, 81:6851 (1984).
L. K. Sun, P. Curtis, E. Rakowicz-Szulczynska, J. Ghrayeh, N. Chang, S. L. Morrison, and H. Koprowski, Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A, Proc. Natl. Acad. Sci. USA, 84:214 (1987).
J. Schlom, D. Wunderlich, and U. A. Teramoto, Generation of human monoclonal antibodies reactive with human mammary carcinoma cells, Proc. Natl. Acad. Sci. USA, 77:6841 (1980).
K. Sikora, and R. Wright, Human monoclonal antibodies to lung cancer antigens, Br. J. Cancer, 43:696 (1981).
J. Sikora, T. Alderson, A. Nethersell, and H. Smedley, Tumor localization by human monoclonal antibodies, Med. Oncol. Tumour Pharmacother 2:77 (1985).
R. J. Cote, D. M. Morrissey, A. N. Houghton, E. J. Beattie, Jr., H. F. Oettgen, and L. J. Old, Generation of human monoclonal antibodies reactive with cellular antigens, Proc. Natl. Acad. Sci. USA, 80:2026 (1983).
A. Iman, M. M. Drushella, C. R. Taylor, and Z. Tokes, Generation and immunohistological characterization of human monoclonal antibodies to mammary carcinoma cells, Cancer Res. 45:263 (1985).
M. G. Hanna, Jr. and L. C. Peters, Immunotherapy of established micrometastases with a Bacillus Calmette Guerin tumor cell vaccine, Cancer Res. 38:204 (1978).
M. G. Hanna, Jr., J. S. Brandhorst, and L. C. Peters, Active specific immunotherapy of residual micrometastases: An evaluation of sources, doses and ratios of BCG with tumor cells, Cancer Immunol. Immunother. 7:165 (1979).
H. C. Hoover, Jr., M. Surkyke, R. B. Dangel, L. C. Peters, and M. G. Hanna, Jr., Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell-Bacillus Calmette Guerin vaccine, Cancer Res. 44:1671 (1984).
H. C. Hoover, Jr., M. G. Surdyke, R. B. Dangel, L. C. Peters, and M. G. Hanna, Jr., Prospectively randomized trial of adjuvant active specific immunotherapy for human colorectal cancer, Cancer 55:1236 (1985).
L. C. Peters, J. S. Brandhorst, and M. G. Hanna, Jr., Preparation of immunotherapeutic autologous tumor cell vaccines from solid tumors. Cancer Res. 39:1353 (1979).
L. C. Peters, and M. G. Hanna, Jr., Active specific immunotherapy of established metastases: Effect of cryopreservation procedures on tumor cell immunogenicity in guinea pigs. J. Nat’l. Cancer Inst. 64:1521 (1980).
M. V. Haspel, R. P. McCabe, N. J. Pomato, J. V. Knowlton, L. C. Peters, H. C. Hoover, Jr., M. G. Hanna, Jr., Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients, Cancer Res. 45:3951 (1985).
H. F. Dvorak, N. S. Orenstein, A. C. Carvalho, W. H. Churchill, A. M. Dvorak, S. J. Galli, J. Feder, A. M. Bitzer, J. Rypysc, and P. Giorinco, Induction of a fibringel investment: An early event in line 10 hepatocarcinoma growth mediated by tumor secreted products, J. Nat’l. Cancer Inst. 122:166 (1979)
W. F. Barth, R. D. Wochner, T. Waldmann, and J. L. Fahey, Metabolism of human gamma macroglobulins, J. Clin. Invest. 6:1036 (1964).
R. P. McCabe, L. C. Peters, M. V. Haspel, N. Pomato, J. A. Carrasquillo, M. G. Hanna, Jr., Human monoclonal antibodies to colorectal cancer: preclinical pharmacokinetic and tumor localization studies, Proc. Amer. Assoc. Cancer Res. (In Press).
R. P. McCabe, L. C. Peters, M. V. Haspel, N. Pomato, J. A. Carrasquillo, M. G. Hanna, Jr., Preclinical pharmacokinetic and tumor localization studies with human monoclonal antibodies to colorectal cancer, Cancer Res. (In press).
B. Ballou, J. Reiland, G. Levine, B. Knowles, and T. R. Hakala, Tumor location using F(ab′)2 from a monoclonal IgM antibody: pharmacokinetics, J. Nucl. Med., 26:283 (1985).
R. W. Baldwin, and M. V. Pimm, Anti-tumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting, Cancer Metastasis Rev. 2:89 (1983).
A. A. Epenetos, W. F. Bodmer and K. E. Britton, Radioimmunodetection of cancer, Eur. J. Cancer Clin. Oncol. 18:1221 (1982).
D. Herlyn, J. Powe, A. Alavi, J. A. Mattis, M. Herlyn, C. Ernst, R. Vaum, and H. Koprowski, Radioimmunodetection of human tumor xenografts by monoclonal antibodies, Cancer Res. 43:2731 (1983).
B. Ballou, G. Levine, T. R. Hakala, and D. Solter, Tumor location detected with radioactively labeled monoclonal antibody and external scintigraphy, Science 206:844 (1979).
A. Hedin, B. Wahren, and S. Hammarstrom, Tumor localization of CEA containing human tumors in nude mice by means of monoclonal anti CEA antibodies, Int. J. Cancer 30:547 (1982).
T. Nakamura, H. Sakahara, S. Hosoi, T. Yamamuro, S. Higashi, H. Mikawo, K. Endo, and S. Tomaya, In vivo radiolocalization of anti osteogenic sarcoma xenografts, Cancer Res. 44:2078 (1984).
D. S. Reintgen, K. Shimizu, E. Coleman, W. Briner, J. Kitzmiller, G. Eisenbarth and H. F. Seigier, Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5, J. Surg. Oncol. 23:205 (1983).
D. Hyams, J. C. Reynolds, J. A. Carrasquillo, P. Perentesis. S. M. Larson, M. Morin, D. Simpson, J. Schlom, and D. Colcher, The effect of circulating anti-murine antibody on the pharmacokinetics and biodistribution of injected radiolabeled monoclonal antibody, J. Nucl. Med. 27:922 (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this paper
Cite this paper
McCabe, R.P., Peters, L.C., Haspel, M.V., Pomato, N., Carrasquillo, J.A. (1988). Development and Characterization of Human Monoclonal Antibodies and Their Application in the Radioimmunodetection of Colon Carcinoma. In: Srivastava, S.C. (eds) Radiolabeled Monoclonal Antibodies for Imaging and Therapy. NATO ASI Series, vol 152. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5538-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5538-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5540-3
Online ISBN: 978-1-4684-5538-0
eBook Packages: Springer Book Archive